CStone Pharmaceuticals has announced that its Board of Directors will hold a meeting on Thursday, August 14, 2025. The meeting's agenda includes considering and approving the unaudited interim results of the company and its subsidiaries for the six months ended June 30, 2025, and discussing the payment of an interim dividend, if applicable.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.